학술논문
Mutations in human immunodeficiency virus type 1 integrase confer resistance to the naphthyridine L-870,810 and cross-resistance to the clinical trial drug GS-9137
Document Type
Article
Author
Source
In: Antimicrobial Agents and Chemotherapy . (Antimicrobial Agents and Chemotherapy, June 2008, 52(6):2069-2078)
Subject
Language
English
ISSN
00664804